Mansouri H, Alcaraz L, Mollevi C, Mallavialle A, Jacot W, Boissiere-Michot F
Cancers (Basel). 2020; 12(5).
PMID: 32429078
PMC: 7281089.
DOI: 10.3390/cancers12051244.
Schmelzer E, Over P, Gridelli B, Gerlach J
J Med Biol Eng. 2016; 36:153-167.
PMID: 27231463
PMC: 4853461.
DOI: 10.1007/s40846-016-0118-z.
Westley R, May F
Int J Endocrinol. 2013; 2013:632461.
PMID: 23983688
PMC: 3747439.
DOI: 10.1155/2013/632461.
Trebinska A, Rembiszewska A, Ciosek K, Ptaszynski K, Rowinski S, Kupryjanczyk J
BMC Cancer. 2010; 10:76.
PMID: 20196840
PMC: 2843675.
DOI: 10.1186/1471-2407-10-76.
Winuthayanon W, Piyachaturawat P, Suksamrarn A, Ponglikitmongkol M, Arao Y, Hewitt S
Environ Health Perspect. 2009; 117(7):1155-61.
PMID: 19654927
PMC: 2717144.
DOI: 10.1289/ehp.0900613.
Thioredoxin and thioredoxin reductase influence estrogen receptor alpha-mediated gene expression in human breast cancer cells.
Rao A, Ziegler Y, McLeod I, Yates J, Nardulli A
J Mol Endocrinol. 2009; 43(6):251-61.
PMID: 19620238
PMC: 2994277.
DOI: 10.1677/JME-09-0053.
Effects of Cu/Zn superoxide dismutase on estrogen responsiveness and oxidative stress in human breast cancer cells.
Rao A, Ziegler Y, McLeod I, Yates J, Nardulli A
Mol Endocrinol. 2008; 22(5):1113-24.
PMID: 18258688
PMC: 2366184.
DOI: 10.1210/me.2007-0381.
Cathepsin D-related disease-free interval in pT1 primary breast carcinomas: a pilot study.
Nikolic-Vukosavljevic D, Markicevic M, Grujic-Adanja G, Petrovic A, Kanjer K, Neskovic-Konstantinovic Z
Clin Exp Metastasis. 2005; 22(4):363-8.
PMID: 16170672
DOI: 10.1007/s10585-005-1265-8.
Molecular mechanism of inhibition of estrogen-induced cathepsin D gene expression by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in MCF-7 cells.
Krishnan V, Porter W, Santostefano M, Wang X, Safe S
Mol Cell Biol. 1995; 15(12):6710-9.
PMID: 8524236
PMC: 230924.
DOI: 10.1128/MCB.15.12.6710.
Prognostic significance of cathepsin-D in patients with breast cancer.
Winstanley J, Leinster S, Cooke T, Westley B, Rudland P
Br J Cancer. 1993; 67(4):767-72.
PMID: 8471433
PMC: 1968341.
DOI: 10.1038/bjc.1993.139.
Cathepsin D gene is controlled by a mixed promoter, and estrogens stimulate only TATA-dependent transcription in breast cancer cells.
Cavailles V, Augereau P, ROCHEFORT H
Proc Natl Acad Sci U S A. 1993; 90(1):203-7.
PMID: 8419924
PMC: 45628.
DOI: 10.1073/pnas.90.1.203.
PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
Gion M, Mione R, Pappagallo G, Gatti C, Nascimben O, Bari M
Br J Cancer. 1993; 68(2):374-9.
PMID: 8347494
PMC: 1968537.
DOI: 10.1038/bjc.1993.343.
B lymphopoiesis: global factors, local control.
Kincade P
Proc Natl Acad Sci U S A. 1994; 91(8):2888-9.
PMID: 8159674
PMC: 43478.
DOI: 10.1073/pnas.91.8.2888.
Mitogenic function of human procathepsin D: the role of the propeptide.
Fusek M, Vetvicka V
Biochem J. 1994; 303 ( Pt 3):775-80.
PMID: 7980446
PMC: 1137614.
DOI: 10.1042/bj3030775.
Western blotting and isoform analysis of cathepsin D from normal and malignant human breast cell lines.
Coronel E, Lange M, Tachovsky T, Longo S, Tucker S, Alhadeff J
Breast Cancer Res Treat. 1995; 35(2):211-20.
PMID: 7647343
DOI: 10.1007/BF00668211.
Estrogens and growth factors induce the mRNA of the 52K-pro-cathepsin-D secreted by breast cancer cells.
Cavailles V, Augereau P, Garcia M, ROCHEFORT H
Nucleic Acids Res. 1988; 16(5):1903-19.
PMID: 3282224
PMC: 338189.
DOI: 10.1093/nar/16.5.1903.
Measurement of oestrogen receptor mRNA levels in human breast tumours.
Henry J, Nicholson S, Farndon J, Westley B, May F
Br J Cancer. 1988; 58(5):600-5.
PMID: 2851309
PMC: 2246829.
DOI: 10.1038/bjc.1988.267.
Expression of human sequences related to those of mouse mammary tumor virus.
Franklin G, Chretien S, Hanson I, ROCHEFORT H, May F, Westley B
J Virol. 1988; 62(4):1203-10.
PMID: 2831381
PMC: 253128.
DOI: 10.1128/JVI.62.4.1203-1210.1988.
Oestrogenic activity of tamoxifen and its metabolites on gene regulation and cell proliferation in MCF-7 breast cancer cells.
Johnson M, Westley B, May F
Br J Cancer. 1989; 59(5):727-38.
PMID: 2736207
PMC: 2247210.
DOI: 10.1038/bjc.1989.153.
Modulation of human breast cancer cell adhesion by estrogens and antiestrogens.
Millon R, Nicora F, Muller D, Eber M, Klein-Soyer C, Abecassis J
Clin Exp Metastasis. 1989; 7(4):405-15.
PMID: 2706828
DOI: 10.1007/BF01753661.